The article Microdose Announces Ninnion Therapeutics as Wonderland 2022 Platinum Sponsor was originally published on Microdose. The leader in the business...
The article News You Might Have Missed: Oct 27th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system...
Cybin Inc. (NEO:CYBN | NYSE American:CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics®”, today announced the...
Eleusis’ IV form of psilocin will see clinical trials, but Eleusis-backed research into the anti-inflammatory properties of psychedelics is uncertain....
The article Microdose Announces MindBio Therapeutics as Wonderland 2022 Platinum Sponsor was originally published on Microdose. The leader in the business...
Wellbeing Digital Sciences Inc. (NEO: MEDI | OTC: KONEF | (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation...
The article Atai Completes Enrollment of Phase 2a Trial for Depression was originally published on Microdose. atai Life Sciences has moved its most advanced...
Awakn Life Sciences Corp. (NEO: AWKN | OTCQB: AWKNF | FSE: 954), a revenue-generating biotechnology company researching, developing, and commercializing...
October 24, 2022 Silo Pharma (NASDAQ: SILO) recently uplisted to the NASDAQ after the exciting progress it made over the last year. “Silo Pharma announced...